Page last updated: 2024-08-22

vidarabine and Refractory Anemia

vidarabine has been researched along with Refractory Anemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Carney, D; Januszewicz, EH; Peinert, S; Prince, HM; Seymour, JF	1

Other Studies

1 other study(ies) available for vidarabine and Refractory Anemia

Article	Year
Fludarabine combinations for patients with advanced marginal zone lymphomas--best treatment option or too toxic? British journal of haematology, 2009, Volume: 146, Issue:6 Topics: Adult; Aged; Aged, 80 and over; Anemia, Refractory; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bone Marrow Diseases; Cell Lineage; Cyclophosphamide; Disease-Free Survival; Drug Therapy, Combination; Humans; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Rituximab; Vidarabine	2009

Article

Year

Fludarabine combinations for patients with advanced marginal zone lymphomas--best treatment option or too toxic?

British journal of haematology, 2009, Volume: 146, Issue:6

Topics: Adult; Aged; Aged, 80 and over; Anemia, Refractory; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Bone Marrow Diseases; Cell Lineage; Cyclophosphamide; Disease-Free Survival; Drug Therapy, Combination; Humans; Lymphoma, B-Cell, Marginal Zone; Middle Aged; Rituximab; Vidarabine

2009